Pipeline
Chemical space drug design
Hit Discovery
Lead Optimization
Preclinical Candidate
IND enabling
| Antivirals | ST-Incofutide-SJ16 Covid-19 inhibitors (First in Class) |
|---|---|
| ST-HBV entrintide HBV inhibitors (Best in Class) | |
| Antimicrobials | ST-T7 broad spectrum (First in Class) |
| ST-M166 Gram-negative bacteria (First in Class) | |
| ST-CAR343 Gram-negative bacteria (First in Class) | |
| Eye | SP-AMD Anti-macular degeneration (Best in Class) |
| Auto-immune | SP-MSD Multiple sclerosis (First in Class) |
| ST-KMC420 JAK inhibitors (Best in Class) | |
| Cancer | SP-CCR8 Solid tumors (Best in Class) |